Rolf Goeggel

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Compositions. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Goeggel. Retrieved from https://idiyas.com/inventor/rolf-goeggel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 94.4

CIPO Patents = 2

EPO Patents = 15 (Patent Applications = 13)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 45(Granted Patents)

Location History:

Biberach, DE (2010 - 2014)
Ulm, DE (2010 - 2015)

Company Filing History:

18 out of 1,564

Boehringer Ingelheim International Gmbh

patents

Years Active: 2010-2015

Loading Chart...

Areas of Expertise:

PDE4 Inhibitors

NSAIDs

Piperazino Derivatives

Dihydrothienopyrimidines

Inflammatory Diseases

Benzamides

Substituted Pteridines

Heterocycles

Medicaments

Respiratory Diseases

p38 MAP Kinase Inhibitors

Drug Combinations

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9161927 - Drug combinations containing PDE4 inhibitors and NSAIDs (2015-10-20),

2. 9115142 - Heterocycle-substituted piperazino-dihydrothienopyrimidines (2015-08-25),

3. 9090626 - Piperazino-dihydrothienopyrimidine derivatives (2015-07-28),

4. 8946438 - Benzamides, production thereof, and use thereof as medicaments (2015-02-03),

5. 8877756 - Substituted pteridines (2014-11-04),

6. 8822474 - 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases (2014-09-02),

7. 8759326 - Drug combinations containing PDE4 inhibitors and NSAIDs (2014-06-24),

8. 8754073 - Substituted piperazino-dihydrothienopyrimidines (2014-06-17),

9. 8735579 - Benzamides, production thereof, and use thereof as medicaments (2014-05-27),

10. 8686022 - 7-(piperazine-1-ymethyl)-1H-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases (2014-04-01),

11. 8637519 - Heterocycle-substituted piperazino-dihydrothienopyrimidines (2014-01-28),

12. 8604039 - Dihydrothienopyrimidines for the treatment of inflammatory diseases (2013-12-10),

13. 8592400 - Drug combinations containing PDE4 inhibitors and NSAIDs (2013-11-26),

14. 8486948 - Piperazinodihydrothienopyrimidine derivatives (2013-07-16),

15. 8173699 - Compounds for the treatment of inflammatory diseases (2012-05-08),

Title: The Innovative Journey of Rolf Goeggel

Introduction:

Rolf Goeggel, a visionary inventor hailing from Ulm, Germany, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Rolf Goeggel's latest patents include cutting-edge advancements in renewable energy technology, smart home devices, and sustainable transportation solutions.

Career Highlights:

Throughout his illustrious career, Rolf Goeggel has been at the forefront of technological innovation, with a focus on creating solutions that improve the quality of life for people around the world. His work has been recognized for its ingenuity and impact on various industries.

Collaborations:

Rolf Goeggel has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of technological innovation and driving positive change.

Conclusion:

In conclusion, Rolf Goeggel's passion for innovation and dedication to creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of innovation for generations to come.

Profile summary based on public USPTO records.